Bioporto AS - Class B BIOPOR

COP: BIOPOR | ISIN: DK0011048619 30/12/2024

1,550 DKK (+9,93%)

(+9,93%) 30/12/2024

Grafiek Bioporto AS - Class B

Grafiek Bioporto AS - Class B

1 dag1d 9,93%
1 week1w 9,93%
1 maand1m -3,73%
3 maanden3m -15,21%
6 maanden6m -27,91%
1 jaar1j -26,54%
5 jaar5j -47,00%

Bioporto AS - Class B in het nieuws

Toon enkel gratis nieuws

16 december 2024 · BioPorto commences process to appoint new Chair of the Board of Directors · Persbericht

14 november 2024 · BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 · Persbericht

4 november 2024 · Grant of Warrants · Persbericht

29 oktober 2024 · First Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital · Persbericht

28 oktober 2024 · BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests · Persbericht

15 augustus 2024 · BioPorto Announces Interim Results and Business Update for the Second Quarter and Six Months of Fiscal 2024 · Persbericht

4 juli 2024 · Grant of Warrants · Persbericht

24 juni 2024 · Managers’ transactions · Persbericht

24 juni 2024 · Changes of number of shares and votes in BioPorto A/S · Persbericht

18 juni 2024 · Private placement of 50,000,000 new shares oversubscribed - gross proceeds of DKK 81.4 million, corresponding to USD 11.7 million, to BioPorto A/S. · Persbericht

Profiel Bioporto AS - Class B

CEO: Peter Moerch Eriksen

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe